pentobarbital has been researched along with Cardiac Hypertrophy in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buccino, RA | 1 |
| Sonnenblick, EH | 1 |
| Spann, JF | 1 |
| Friedman, WF | 1 |
| Braunwald, E | 1 |
1 other study available for pentobarbital and Cardiac Hypertrophy
| Article | Year |
|---|---|
Interactions between changes in the intensity and duration of the active state in the characterization of inotropic stimuli on heart muscle.
Topics: Acetylcholine; Animals; Calcium; Cardanolides; Cardiomegaly; Cats; Electric Stimulation; Heart; Hype | 1967 |